Precision medicine enables doctors to treat cancer patients on an individualized basis, thus increasing the chances of being cured. German Genethics assists them in finding the right therapy for each patient.
Optimal therapy with the aid of Big Data: German Genethics combines the molecular-genetic diagnosis of individual cancerous tissue with the cumulative knowledge about various cancerous conditions and their treatment. This results in a well-founded individual treatment plan.
The German Genethics database, which is unique throughout the world, links information from renowned trade journals and highly specialized molecular-biological databases with the latest research results from clinical trials and knowledge about recognized treatments. By means of complex algorithms, this Big Data solution can sort the characteristics of each individual DNA sample. “Big Data” thus becomes “Smart Data”.
Using the most modern procedures of Next Generation Sequencing (NGS), German Genethics analyses the DNA of the cancerous tissue obtained from the patient. The database compares the tumor DNA with other cases and reviews the treatment options. A written recommendation for the doctor then summarizes all of the relevant information regarding suitable therapies.
A project of the following companies and research facilities
Details as per § 5 TMG
Operator and contact details
Frankfurter Innovationszentrum Biotechnologie GmbH
60438 Frankfurt am Main GERMANY
Phone: +49 (0) 69 800 865-0
Fax: +49 (0)69 800 865 19
Email: info( at )fiz-biotech.de
Frankfurter Innovationszentrum Biotechnologie GmbH is represented by
Dr. Christian Garbe
Registry and registry number: Frankfurt am Main HRB 55518
VAT ID no.:
Publication details on this website created using the generator of the Deutsche Anwaltshotline AG